Lexicon Pharmaceuticals OverviewLexicon Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for LXRX.
Quarterly Other Income/Expense
-$47000.00
↓ 112.24% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$1.86M
↓ 1250% YoY
Trailing 12 months ending Mar 31, 2026